Results 41 to 50 of about 617,785 (192)

SIMULTANEOUS ESTIMATION OF MONTELUKAST SODIUM AND THEOPHYLLINE IN PHARMACEUTICAL DOSAGE FORM BY UV SPECTROPHOTOMETRIC METHOD [PDF]

open access: yes, 2020
A simple, precise, accurate, rapid and economical spectrophotometric method have been developed for simultaneous estimation of Montelukast sodium and Theophylline in pure and in combined tablet dosage form.
Na   +1 more
core  

Efficiency of Using Antiinflammatory Drug with Antileukotriene Action — Montelukast Sodium as a Mean of Controlled Therapy of Bronchial Asthma and Allergic Rhinitis in Children

open access: yesZdorovʹe Rebenka, 2016
The article presents modern approaches to the problem of bronchial asthma and allergic rhinitis as comorbid pathology in children. We have considered the concept of a single chronic allergic respiratory syndrome.
O.M. Оkhotnikova
doaj   +1 more source

Molecular profiling of individual FDA-approved clinical drugs identifies modulators of nonsense-mediated mRNA decay

open access: yesMolecular Therapy: Nucleic Acids, 2022
Nonsense-mediated mRNA decay (NMD) degrades transcripts with premature stop codons. Given the prevalence of nonsense single nucleotide polymorphisms (SNPs) in the general population, it is urgent to catalog the effects of clinically approved drugs on NMD
Jingrong Zhao   +6 more
doaj   +1 more source

Development and Evaluation of Orally Disintegrating Tablets of Montelukast Sodium by Direct Compression Method [PDF]

open access: yes, 2015
Purpose: To design an orally disintegrating montelukast sodium tablet (ODT) that disintegrates in the oral cavity leaving an easy-to-swallow residue especially for pediatric and elderly patients who have difficulty swallowing tablets.Methods: Two ...
Zaheer, K   +5 more
core   +1 more source

FORMULATION AND EVALUATION OF MONTELUKAST SODIUM AND LEVOCETIRIZINE DIHYDROCHLORIDE SUBLINGUAL TABLETS [PDF]

open access: yes, 2015
 Objective: The objective of the current study was to develop and optimize sublingual tablets of montelukast sodium and levocetirizine dihydrochloridewhich are effective drugs in the treatment of asthma.Methods: The sublingual tablets of montelukast ...
SRINIVAS, PRATHIMA, k, SWAPNA, c, APARNA
core   +1 more source

Pharmacokinetic and Pharmacodynamic Interactions Between Anti‐Asthma Drugs and Medicinal Plants: A Comprehensive Review

open access: yesPhytotherapy Research, EarlyView.
ABSTRACT Asthma affects 260–300 million people worldwide. About 20%–35% of patients use medicinal plants with their asthma medication, often without telling their clinicians. Disclosure rates are low; up to 42% of asthma outpatients use herbal products, with no records in their charts.
Emine Kocyigit   +5 more
wiley   +1 more source

The Protective Effects of Diclofenac Sodium and Montelukast Sodium on Acute Inflammation in Traumatic Spinal Cord Injury: An Experimental Study in Rats

open access: yesNamık Kemal Tıp Dergisi, 2022
Aim:The aim of this study was to investigate the protective effects of diclofenac sodium (DF) and montelukast sodium (ML) on acute inflammation in traumatic spinal cord injury (T-SCI).Materials and Methods:Forty Sprague-Dawley rats were randomly divided ...
Taner ENGİN   +6 more
doaj   +1 more source

Parasomnias and sleep‐related movement disorders induced by drugs in the adult population: a review about iatrogenic medication effects

open access: yesJournal of Sleep Research, Volume 34, Issue 2, April 2025.
Summary Parasomnias and sleep‐related movement disorders (SRMD) are major causes of sleep disorders and may be drug induced. The objective of this study was to conduct a systematic review of the literature to examine the association between drug use and the occurrence of parasomnias and SRMD.
Sylvain Dumont   +5 more
wiley   +1 more source

Research progress of combined treatment of western medicine in children with allergic purpura (儿童过敏性紫癜西药联合治疗的研究进展)

open access: yes中西医结合护理, 2021
Allergic purpura, as an allergic microvascular allergic disease, mostly occurs in children. Clinical manifestations include skin purpura, joint pain, abdominal pain and kidney damage.
HU Yuan (胡园)   +2 more
doaj   +1 more source

Maternal nutrition as a key determinant of placental and developing blood–brain barrier xenobiotic protective functions

open access: yesThe Journal of Physiology, EarlyView.
Abstract figure legend Suboptimal maternal nutrition alters placental and developing blood–brain barrier (BBB) protective function and is associated with increased fetal brain vulnerability. In the placenta, nutritional adversity may reduce the exchange surface area and promote meta‐inflammation, compromising barrier efficiency in a model‐ and context ...
Kristin L. Connor   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy